CollPlant Biotechnologies
CLGN
CLGN
16 hedge funds and large institutions have $51.9M invested in CollPlant Biotechnologies in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
16
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.9M | |
| 2 | +$3.74M | |
| 3 | +$276K | |
| 4 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$106K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$17.8K |
Top Sellers
| 1 | -$734K | |
| 2 | -$318K | |
| 3 | -$265K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$229K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$134K |